KR100740730B1 - 중합체 섬유 조성물 및 방법 - Google Patents
중합체 섬유 조성물 및 방법 Download PDFInfo
- Publication number
- KR100740730B1 KR100740730B1 KR1020047015048A KR20047015048A KR100740730B1 KR 100740730 B1 KR100740730 B1 KR 100740730B1 KR 1020047015048 A KR1020047015048 A KR 1020047015048A KR 20047015048 A KR20047015048 A KR 20047015048A KR 100740730 B1 KR100740730 B1 KR 100740730B1
- Authority
- KR
- South Korea
- Prior art keywords
- delete delete
- particles
- wavelength
- light
- user
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims description 39
- 239000000203 mixture Substances 0.000 title abstract description 56
- 229920005594 polymer fiber Polymers 0.000 title 1
- 239000002245 particle Substances 0.000 claims abstract description 101
- 239000000463 material Substances 0.000 claims abstract description 50
- 239000012876 carrier material Substances 0.000 claims abstract description 21
- 238000009826 distribution Methods 0.000 claims description 19
- 239000011149 active material Substances 0.000 claims description 15
- 230000005855 radiation Effects 0.000 claims description 15
- 239000013543 active substance Substances 0.000 claims description 5
- 230000002829 reductive effect Effects 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000012798 spherical particle Substances 0.000 claims 1
- 239000000835 fiber Substances 0.000 abstract description 57
- 239000000843 powder Substances 0.000 abstract description 37
- 229920005989 resin Polymers 0.000 abstract description 34
- 239000011347 resin Substances 0.000 abstract description 34
- 230000003287 optical effect Effects 0.000 abstract description 16
- 238000001429 visible spectrum Methods 0.000 abstract description 7
- 239000004753 textile Substances 0.000 abstract description 4
- 230000015572 biosynthetic process Effects 0.000 abstract description 3
- 238000000576 coating method Methods 0.000 abstract description 3
- 239000012467 final product Substances 0.000 abstract description 3
- 230000004927 fusion Effects 0.000 abstract description 2
- 239000011810 insulating material Substances 0.000 abstract description 2
- 230000001681 protective effect Effects 0.000 abstract description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 49
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 28
- 238000012360 testing method Methods 0.000 description 28
- 229920000728 polyester Polymers 0.000 description 24
- 239000004408 titanium dioxide Substances 0.000 description 24
- 235000012239 silicon dioxide Nutrition 0.000 description 23
- 239000010453 quartz Substances 0.000 description 22
- 239000000126 substance Substances 0.000 description 20
- 210000000707 wrist Anatomy 0.000 description 20
- 230000003595 spectral effect Effects 0.000 description 19
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 16
- 229910052760 oxygen Inorganic materials 0.000 description 16
- 239000001301 oxygen Substances 0.000 description 16
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 15
- 230000008859 change Effects 0.000 description 13
- 239000004744 fabric Substances 0.000 description 13
- 238000001228 spectrum Methods 0.000 description 13
- 238000009987 spinning Methods 0.000 description 13
- 230000001965 increasing effect Effects 0.000 description 12
- 210000003491 skin Anatomy 0.000 description 12
- 229920000742 Cotton Polymers 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 210000003205 muscle Anatomy 0.000 description 11
- 229940068196 placebo Drugs 0.000 description 10
- 239000000902 placebo Substances 0.000 description 10
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 9
- 210000002683 foot Anatomy 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- 210000004247 hand Anatomy 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 229920002334 Spandex Polymers 0.000 description 6
- 230000005284 excitation Effects 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 239000004759 spandex Substances 0.000 description 6
- 229920002994 synthetic fiber Polymers 0.000 description 6
- 239000012209 synthetic fiber Substances 0.000 description 6
- 244000025254 Cannabis sativa Species 0.000 description 5
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 5
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 5
- 235000009120 camo Nutrition 0.000 description 5
- 235000005607 chanvre indien Nutrition 0.000 description 5
- 239000011487 hemp Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 230000029663 wound healing Effects 0.000 description 5
- 239000004677 Nylon Substances 0.000 description 4
- 229920000297 Rayon Polymers 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- 238000001125 extrusion Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 238000000227 grinding Methods 0.000 description 4
- 238000009413 insulation Methods 0.000 description 4
- 229920001778 nylon Polymers 0.000 description 4
- 239000002964 rayon Substances 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- 240000000491 Corchorus aestuans Species 0.000 description 3
- 235000011777 Corchorus aestuans Nutrition 0.000 description 3
- 235000010862 Corchorus capsularis Nutrition 0.000 description 3
- 210000003423 ankle Anatomy 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 210000003470 mitochondria Anatomy 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 229910052814 silicon oxide Inorganic materials 0.000 description 3
- 210000002268 wool Anatomy 0.000 description 3
- 230000006820 DNA synthesis Effects 0.000 description 2
- 241000208202 Linaceae Species 0.000 description 2
- 235000004431 Linum usitatissimum Nutrition 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 238000002266 amputation Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008081 blood perfusion Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 230000005670 electromagnetic radiation Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000009920 food preservation Methods 0.000 description 2
- 230000013632 homeostatic process Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 230000010412 perfusion Effects 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 210000001626 skin fibroblast Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 238000012353 t test Methods 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000002759 woven fabric Substances 0.000 description 2
- ZAUYNCUCMJDAHW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;hydrogen peroxide;molecular iodine Chemical compound OO.II.C=CN1CCCC1=O ZAUYNCUCMJDAHW-UHFFFAOYSA-N 0.000 description 1
- 208000030090 Acute Disease Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 206010002942 Apathy Diseases 0.000 description 1
- 206010068975 Bone atrophy Diseases 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- 206010051055 Deep vein thrombosis Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 206010023230 Joint stiffness Diseases 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 206010028289 Muscle atrophy Diseases 0.000 description 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 208000018262 Peripheral vascular disease Diseases 0.000 description 1
- 239000004962 Polyamide-imide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 229920003027 Thinsulate Polymers 0.000 description 1
- 239000004789 Thinsulate Substances 0.000 description 1
- 229910010413 TiO 2 Inorganic materials 0.000 description 1
- 208000024248 Vascular System injury Diseases 0.000 description 1
- 208000012339 Vascular injury Diseases 0.000 description 1
- 206010047249 Venous thrombosis Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 206010001584 alcohol abuse Diseases 0.000 description 1
- 208000025746 alcohol use disease Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000009529 body temperature measurement Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 239000002254 cytotoxic agent Substances 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000007730 finishing process Methods 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000003284 homeostatic effect Effects 0.000 description 1
- 238000002639 hyperbaric oxygen therapy Methods 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000007734 materials engineering Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000001872 metatarsal bone Anatomy 0.000 description 1
- 230000005486 microgravity Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 238000001126 phototherapy Methods 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 229920002312 polyamide-imide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 239000011116 polymethylpentene Substances 0.000 description 1
- 229920000306 polymethylpentene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 229960004618 prednisone Drugs 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011342 resin composition Substances 0.000 description 1
- 239000012260 resinous material Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 201000009032 substance abuse Diseases 0.000 description 1
- 231100000736 substance abuse Toxicity 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- GEVPIWPYWJZSPR-UHFFFAOYSA-N tcpo Chemical compound ClC1=CC(Cl)=CC(Cl)=C1OC(=O)C(=O)OC1=C(Cl)C=C(Cl)C=C1Cl GEVPIWPYWJZSPR-UHFFFAOYSA-N 0.000 description 1
- 230000002277 temperature effect Effects 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000007631 vascular surgery Methods 0.000 description 1
Images
Classifications
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F1/00—General methods for the manufacture of artificial filaments or the like
- D01F1/02—Addition of substances to the spinning solution or to the melt
- D01F1/10—Other agents for modifying properties
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F1/00—General methods for the manufacture of artificial filaments or the like
- D01F1/02—Addition of substances to the spinning solution or to the melt
- D01F1/10—Other agents for modifying properties
- D01F1/106—Radiation shielding agents, e.g. absorbing, reflecting agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
- Y10T428/1352—Polymer or resin containing [i.e., natural or synthetic]
- Y10T428/1362—Textile, fabric, cloth, or pile containing [e.g., web, net, woven, knitted, mesh, nonwoven, matted, etc.]
Landscapes
- Engineering & Computer Science (AREA)
- Manufacturing & Machinery (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Textile Engineering (AREA)
- Artificial Filaments (AREA)
- Radiation-Therapy Devices (AREA)
- Undergarments, Swaddling Clothes, Handkerchiefs Or Underwear Materials (AREA)
- Bedding Items (AREA)
- Professional, Industrial, Or Sporting Protective Garments (AREA)
- Gloves (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Paints Or Removers (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36623702P | 2002-03-22 | 2002-03-22 | |
| US60/366,237 | 2002-03-22 | ||
| US41553202P | 2002-10-02 | 2002-10-02 | |
| US60/415,532 | 2002-10-02 | ||
| PCT/US2003/008910 WO2003083189A1 (en) | 2002-03-22 | 2003-03-24 | Polymeric fiber composition and method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20040104539A KR20040104539A (ko) | 2004-12-10 |
| KR100740730B1 true KR100740730B1 (ko) | 2007-07-19 |
Family
ID=28678165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020047015048A Expired - Lifetime KR100740730B1 (ko) | 2002-03-22 | 2003-03-24 | 중합체 섬유 조성물 및 방법 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20040043174A1 (https=) |
| EP (1) | EP1488026B1 (https=) |
| JP (2) | JP4489439B2 (https=) |
| KR (1) | KR100740730B1 (https=) |
| AT (1) | ATE460514T1 (https=) |
| AU (1) | AU2003220481B2 (https=) |
| CA (1) | CA2479958C (https=) |
| DE (1) | DE60331636D1 (https=) |
| ES (1) | ES2341765T3 (https=) |
| PT (1) | PT1488026E (https=) |
| WO (1) | WO2003083189A1 (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8486318B2 (en) | 2011-03-11 | 2013-07-16 | Optopac Co., Ltd. | Fiber, fiber aggregate and adhesive having the same |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7100352B2 (en) | 2004-01-21 | 2006-09-05 | Robins Steven D | Protective composite yarn |
| CA2712513A1 (en) * | 2007-01-31 | 2008-08-07 | Innovision Headwear Inc. | Optically active headgear |
| US20090291108A1 (en) * | 2008-05-25 | 2009-11-26 | Tsai-Chin Chen | Fabric with health care component |
| US20110107502A1 (en) * | 2009-11-12 | 2011-05-12 | Todd Dalhausser | Training and recovery clothing and related methods |
| JP5597021B2 (ja) * | 2010-04-15 | 2014-10-01 | オリンパス株式会社 | 画像処理装置及びプログラム |
| US20110277216A1 (en) * | 2010-05-13 | 2011-11-17 | Alan Norman Higgins | Fiber material |
| US20220218115A1 (en) * | 2017-08-27 | 2022-07-14 | Under Armour, Inc. | Bedding for a mattress |
| US10252945B2 (en) | 2012-09-26 | 2019-04-09 | Multiple Energy Technologies Llc | Bioceramic compositions |
| ES2492215B1 (es) | 2013-02-06 | 2015-06-29 | Jesús CANDEL FABREGAS | Polvo cerámico fotocatalítico y de emisión infrarroja, aplicable a fibras textiles y procedimiento de obtención de dicho polvo |
| SE537818C2 (sv) * | 2013-04-05 | 2015-10-27 | Ten Medical Design Ab | Strålskyddande material |
| ITMI20131095A1 (it) | 2013-06-28 | 2014-12-29 | Allergosystem S R L | Tessuto e filato con proprieta' ossigenanti |
| US20170049890A1 (en) | 2014-05-05 | 2017-02-23 | Multiple Energy Technologies Llc | Bioceramic compositions and biomodulatory uses thereof |
| PL3199673T3 (pl) * | 2014-09-24 | 2020-12-28 | Kai-Li Huang | Włókna do kontrolowania środowiska na podstawie zielonej energii, sposób ich wytwarzania oraz wykonana z nich tkanina |
| WO2017018470A1 (ja) * | 2015-07-27 | 2017-02-02 | 国立研究開発法人理化学研究所 | 発光装置、発光システム、及び、発光装置の製造方法 |
| US10337124B2 (en) * | 2015-08-26 | 2019-07-02 | Teague Egan | Textile graphene component thermal fiber |
| AU2020209227A1 (en) * | 2019-01-16 | 2021-08-19 | Hologenix, Llc | Cellulose and semi-cellulose based fibers and yarns embedded with mineral particles and methods of making the same |
| MX2023015261A (es) * | 2021-06-23 | 2024-01-19 | Beiersdorf Ag Star | Recubrimiento para heridas para aumentar la concentracion de no en las heridas. |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5466526A (en) | 1992-07-16 | 1995-11-14 | Magata; Katsumi | Far infrared radiant composite fiber containing metal |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1415313A (en) * | 1918-10-15 | 1922-05-09 | William M Cavanaugh | Method of making leather yarn and article |
| US1713113A (en) * | 1927-10-01 | 1929-05-14 | William M Cavanaugh | Leather manufacture |
| FR2384836A1 (fr) * | 1977-03-25 | 1978-10-20 | Bric | Textiles photoluminescents par enduction |
| JPH03190990A (ja) * | 1989-12-20 | 1991-08-20 | Toshio Komuro | 赤外線微弱エネルギー放射用の粉末及びそれを混入した合成繊維 |
| DE4142240A1 (de) * | 1991-12-20 | 1993-06-24 | Basf Ag | Verwendung von pigmentpraeparationen zum pigmentieren oder mattieren von zurichtmitteln fuer leder und lederimitate |
| US5851668A (en) * | 1992-11-24 | 1998-12-22 | Hoechst Celanese Corp | Cut-resistant fiber containing a hard filler |
| IL109236A (en) * | 1993-04-13 | 1998-01-04 | Sumitomo Chemical Co | A-alumina powder and its production |
| CA2221138A1 (en) * | 1995-06-06 | 1996-12-12 | Kimberly-Clark Worldwide, Inc. | Microporous fabric containing a microbial adsorbent |
| DE19647038B4 (de) * | 1996-11-14 | 2007-02-22 | Ferro Gmbh | Kugelförmige Pigmente, Verfahren zu ihrer Herstellung und deren Verwendung |
| US5779950A (en) * | 1996-12-02 | 1998-07-14 | Kang; Dong Soon | Method of making a synthetic fiber containing infrared energy powder |
| TWI285671B (en) * | 1998-10-13 | 2007-08-21 | Orion 21 A D Pty Ltd | Luminescent gel coats and moldable resins |
| US6332993B1 (en) * | 1999-09-16 | 2001-12-25 | Nan Ya Plastics Corporation | Process of making heat-retaining fibers |
| CA2406102A1 (en) * | 2000-05-19 | 2002-10-22 | Toshio Komuro | Far infrared radiation composition having excellent static-eliminating properties, and fiber and fiber product comprising the same |
| US20020035755A1 (en) * | 2000-06-14 | 2002-03-28 | Widdemer John D. | Interactive leather for gloves, shoes, garments and upholstery |
| JP4175558B2 (ja) * | 2002-07-23 | 2008-11-05 | 株式会社ファーベスト | 遠赤外線放射材料 |
-
2003
- 2003-03-24 KR KR1020047015048A patent/KR100740730B1/ko not_active Expired - Lifetime
- 2003-03-24 JP JP2003580616A patent/JP4489439B2/ja not_active Expired - Lifetime
- 2003-03-24 ES ES03716790T patent/ES2341765T3/es not_active Expired - Lifetime
- 2003-03-24 US US10/396,132 patent/US20040043174A1/en not_active Abandoned
- 2003-03-24 WO PCT/US2003/008910 patent/WO2003083189A1/en not_active Ceased
- 2003-03-24 DE DE60331636T patent/DE60331636D1/de not_active Expired - Lifetime
- 2003-03-24 CA CA002479958A patent/CA2479958C/en not_active Expired - Fee Related
- 2003-03-24 AT AT03716790T patent/ATE460514T1/de not_active IP Right Cessation
- 2003-03-24 EP EP03716790A patent/EP1488026B1/en not_active Expired - Lifetime
- 2003-03-24 PT PT03716790T patent/PT1488026E/pt unknown
- 2003-03-24 AU AU2003220481A patent/AU2003220481B2/en not_active Expired
-
2008
- 2008-07-02 JP JP2008173997A patent/JP2008231657A/ja active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5466526A (en) | 1992-07-16 | 1995-11-14 | Magata; Katsumi | Far infrared radiant composite fiber containing metal |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8486318B2 (en) | 2011-03-11 | 2013-07-16 | Optopac Co., Ltd. | Fiber, fiber aggregate and adhesive having the same |
| KR101345694B1 (ko) * | 2011-03-11 | 2013-12-30 | 옵토팩 주식회사 | 파이버, 파이버 집합체 및 이를 포함하는 접착제 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008231657A (ja) | 2008-10-02 |
| ATE460514T1 (de) | 2010-03-15 |
| CA2479958A1 (en) | 2003-10-09 |
| DE60331636D1 (de) | 2010-04-22 |
| AU2003220481B2 (en) | 2007-11-22 |
| JP2005520950A (ja) | 2005-07-14 |
| KR20040104539A (ko) | 2004-12-10 |
| PT1488026E (pt) | 2010-05-31 |
| US20040043174A1 (en) | 2004-03-04 |
| AU2003220481A1 (en) | 2003-10-13 |
| CA2479958C (en) | 2009-11-03 |
| JP4489439B2 (ja) | 2010-06-23 |
| EP1488026B1 (en) | 2010-03-10 |
| WO2003083189A1 (en) | 2003-10-09 |
| EP1488026A1 (en) | 2004-12-22 |
| ES2341765T3 (es) | 2010-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100740730B1 (ko) | 중합체 섬유 조성물 및 방법 | |
| US7074499B2 (en) | Polymeric fiber composition and method | |
| KR101320279B1 (ko) | 중합체 조성물, 중합체 조성물의 제조 방법, 상기 중합체 조성물 기재의 물품, 및 상기 물품의 용도 | |
| US20110107502A1 (en) | Training and recovery clothing and related methods | |
| US11998759B2 (en) | Electrically passive low-level light therapy system and methods incorporating same | |
| CN108606373A (zh) | 生物智能保健服 | |
| RU2746333C2 (ru) | Косметическая ткань | |
| KR100887376B1 (ko) | 보습 원단 | |
| Dyer | Infrared functional textiles | |
| KR101904105B1 (ko) | 원적외선 방사능이 있는 옥 분말이 함유된 원사의 제조 방법 및 이에 의해 제조된 원사를 이용한 침구원단 | |
| KR20170045822A (ko) | 미용용 마스크 팩 | |
| WO2020144388A1 (es) | Material textil con microparticulas biocerámicas que emite en el infrarrojo lejano en cuatro longitudes de onda concretras simultáneamente | |
| KR20090050578A (ko) | 이중표면구조의 천연광물 함유 다기능성 원단 | |
| Yüce | Yarns emitting far infrared rays | |
| JP2004316005A (ja) | 繊維構造物 | |
| AU2016421086B2 (en) | Polymer material comprising at least one different doping element, uses and production method | |
| KR20140134983A (ko) | 생체활성 에너지를 방사하는 의류용 섬유시트 | |
| KR102399087B1 (ko) | 휴대용 무좀 치료장치 | |
| KR20230029041A (ko) | 항균성을 가지고 흡한속건사로 제직된 양말의 제조방법, 및 항균성을 가지고 흡한속건사로 제직된 양말의 제조방법에 의해 제조된 양말 | |
| ElNashar | Effect the design and materials of eyesswathe dressing and diapers clothes for Infant’s Incubator | |
| CN107752161A (zh) | 防紫外线防日晒纳米元素织物户外运动服 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20040922 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| N231 | Notification of change of applicant | ||
| PN2301 | Change of applicant |
Patent event date: 20041116 Comment text: Notification of Change of Applicant Patent event code: PN23011R01D |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20051110 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20061024 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20070423 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20070711 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20070711 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration | ||
| PR1001 | Payment of annual fee |
Payment date: 20100707 Start annual number: 4 End annual number: 4 |
|
| PR1001 | Payment of annual fee |
Payment date: 20110729 Start annual number: 5 End annual number: 5 |
|
| PR1001 | Payment of annual fee |
Payment date: 20120620 Start annual number: 6 End annual number: 6 |
|
| FPAY | Annual fee payment |
Payment date: 20130620 Year of fee payment: 7 |
|
| PR1001 | Payment of annual fee |
Payment date: 20130620 Start annual number: 7 End annual number: 7 |
|
| FPAY | Annual fee payment |
Payment date: 20140702 Year of fee payment: 8 |
|
| PR1001 | Payment of annual fee |
Payment date: 20140702 Start annual number: 8 End annual number: 8 |
|
| FPAY | Annual fee payment |
Payment date: 20150618 Year of fee payment: 9 |
|
| PR1001 | Payment of annual fee |
Payment date: 20150618 Start annual number: 9 End annual number: 9 |
|
| FPAY | Annual fee payment |
Payment date: 20160711 Year of fee payment: 10 |
|
| PR1001 | Payment of annual fee |
Payment date: 20160711 Start annual number: 10 End annual number: 10 |
|
| FPAY | Annual fee payment |
Payment date: 20170616 Year of fee payment: 11 |
|
| PR1001 | Payment of annual fee |
Payment date: 20170616 Start annual number: 11 End annual number: 11 |
|
| FPAY | Annual fee payment |
Payment date: 20190617 Year of fee payment: 13 |
|
| PR1001 | Payment of annual fee |
Payment date: 20190617 Start annual number: 13 End annual number: 13 |
|
| PR1001 | Payment of annual fee |
Payment date: 20200618 Start annual number: 14 End annual number: 14 |
|
| PC1801 | Expiration of term |
Termination date: 20230924 Termination category: Expiration of duration |